Apyx Medical (APYX) Total Debt Growth (3y) (2013 - 2026)
Powered by 
Analysis
Apyx Medical (APYX) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -10.56% |
| 10 | Apyx Medical | 125.85 Mn | 98.23 Mn | 8.87 Mn | 25.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.71% |
| Mar 31, 2026 | 25.96% |
| Sep 30, 2023 | 300.73% |
| Jun 30, 2023 | 402.69% |
| Mar 31, 2023 | 400.53% |
| Sep 30, 2020 | -63.97% |
| Jun 30, 2020 | -64.21% |
| Mar 31, 2020 | -64.44% |
| Dec 31, 2019 | -63.73% |
| Sep 30, 2019 | -63.97% |
| Jun 30, 2019 | -64.21% |
| Mar 31, 2019 | -64.96% |
| Dec 31, 2018 | -64.66% |
| Sep 30, 2018 | -64.88% |
| Jun 30, 2018 | -5.11% |
| Mar 31, 2018 | -5.01% |
| Dec 31, 2017 | -7.57% |
| Sep 30, 2017 | -4.82% |
| Dec 31, 2016 | -3.43% |
| Mar 31, 2016 | -1.32% |